CDC recommends second COVID-19 bivalent booster for older adults, immunocompromised 

Apr 20, 2023 - 01:44 PM
Black person receiving vaccination in arm

The Centers for Disease Control and Prevention April 19 recommended a second Moderna or Pfizer COVID-19 bivalent vaccine dose for adults aged 65 and older at least four months after their initial bivalent dose, and for immunocompromised individuals at least two months after their initial bivalent dose, as authorized by the Food and Drug Administration. Immunocompromised individuals also may receive additional bivalent vaccine doses at the discretion of their health care provider. In addition, CDC continues to recommend a single Moderna or Pfizer COVID-19 bivalent vaccine dose for all Americans aged 6 and older. 

The FDA no longer authorizes the monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines for use in the United States. CDC’s recommendations for use of the monovalent Novavax and Johnson & Johnson COVID-19 vaccines remain unchanged.

CDC and its Advisory Committee on Immunization Practices “will continue to monitor COVID-19 disease levels and vaccine effectiveness in the months ahead and look forward to additional discussion around potential updates this fall,” CDC said.

Related News Articles

Headline
ACIP recommends patients consult their provider for COVID-19 vaccine
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
FDA issues serious recall for electric wheelchair joysticks
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
CDC says COVID-19 cases growing or likely growing in 45 states 
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
COVID-19 vaccination approved for older adults and high-risk, younger children
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…
Headline
RFK Jr. says CDC will no longer recommend COVID-19 vaccine for healthy children, pregnant women
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention…